Antipodean Advisors’s Bausch Health BHC Stock Holding History

Antipodean Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-413,232	Closed	-$91.8M	–	30
2015 Q2	$91.8M	Sell	413,232 -151,000	-27%	-$33.5M	9.5%	3
2015 Q1	$112M	Sell	564,232 -29,000	-5%	-$5.14M	10.47%	2
2014 Q4	$84.9M	Sell	593,232 -55,329	-9%	-$7.44M	7.59%	4
2014 Q3	$85.1M	Sell	648,561 -516,639	-44%	-$61.6M	8.29%	3
2014 Q2	$147M	Buy	1,165,200 +312,000	+37%	+$39.8M	10.98%	2
2014 Q1	$112M	Sell	853,200 -74,000	-8%	-$10.1M	10.5%	4
2013 Q4	$109M	Sell	927,200 -172,300	-16%	-$18.9M	9.42%	3
2013 Q3	$115M	Sell	1,099,500 -33,000	-3%	-$3.21M	11.97%	1
2013 Q2	$97.5M	Buy	+1,132,500	New	+$89.2M	10.23%	2

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Antipodean Advisors's BHC Position: Q3 2015 in Review

Antipodean Advisors sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 413,232 shares — an estimated $91.8M sold.

Antipodean Advisors first reported a position in BHC in Q2 2013 and held it in 9 quarters. The position peaked at $147M in Q2 2014. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

Antipodean Advisors reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
Antipodean Advisors sold 413,232 Bausch Health shares in Q3 2015, an estimated $91.8M.
Antipodean Advisors first reported a position in Bausch Health in Q2 2013 and held it in 9 quarters.
Antipodean Advisors's Bausch Health position peaked at $147M in Q2 2014.
546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Antipodean Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.